New Zealand - English - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - dexchlorpheniramine maleate 6mg (overage of 5.5% used during manufacture) - modified release tablet - 6 mg - active: dexchlorpheniramine maleate 6mg (overage of 5.5% used during manufacture) excipient: acacia calcium phosphate calcium sulfate dihydrate carnauba wax colophony gelatin soap: schering-plough company monograph lactose monohydrate magnesium stearate maize starch methyl hydroxybenzoate oleic acid purified talc sucrose white beeswax zein

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - levamisole hydrochloride; albendazole oxide - oral solution/suspension - levamisole hydrochloride anthelmintic active 82.5 g/l; albendazole oxide carbamate-benzimidazole active 36.0 g/l - parasiticides

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 250 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; lactose; stearic acid; gelatin; titanium dioxide; sodium starch glycollate; tartaric acid; colloidal anhydrous silica; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 100 mg - capsule, hard - excipient ingredients: tartaric acid; sodium lauryl sulfate; iron oxide red; lactose; colloidal anhydrous silica; stearic acid; gelatin; sodium starch glycollate; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 20 mg - capsule, hard - excipient ingredients: tartaric acid; colloidal anhydrous silica; iron oxide yellow; gelatin; lactose; sodium lauryl sulfate; stearic acid; titanium dioxide; sodium starch glycollate; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; simethicone - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 5 mg - capsule, hard - excipient ingredients: indigo carmine; sodium lauryl sulfate; tartaric acid; iron oxide yellow; lactose; colloidal anhydrous silica; sodium starch glycollate; gelatin; stearic acid; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - clostridium septicum toxoid; clostridium tetani toxoid; clostridium perfringens type d toxoid; clostridium novyi type b toxoid/cells; clostridium chauvoei toxoid/cells - clostridium septicum toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium perfringens type d toxoid 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - gonadotrophin (gnrf poly albumin) - gonadotrophin (gnrf poly albumin) 0.3 thou iu/ml - endocrine agent (hormone)

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - dexamethasone - dexamethasone 2 g/litre - endocrine agent (hormone)

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - leptospira interrogans serovar hardjoprajitno; leptospira interrogans serovar pomona - leptospira interrogans serovar hardjoprajitno 0 vaccine; leptospira interrogans serovar pomona 0 vaccine - vaccine